Umut Gökalp, Chairman of Association of Research Based Medical Technologies Manufacturers (ARTED), said that the ‘value-based purchasing system’ referring to the purchase of medical devices for the total benefit they finally provide is more advantageous than the price-based purchase in terms of both the use of advanced technology and cost.
Answering the questions asked by DÜNYA, Umut Gökalp said
“This is the present situation. When it comes down to the price only, suppliers having the highest financial strength always win. If we can create niches where 20% of the total demand is manufactured at domestic level, not imported, it will be a great success.”
Emphasizing that lower prices and longer payment terms are advantageous only for suppliers having strong financial structures, Gökalp said “Many suppliers are unable to compete with those offering both lower prices and longer payment terms, so that they go bankrupt, and some international suppliers have to close down some of their departments.
Furthermore, the rules governing the payment of medical devices and medical services bought were not updated for the costs increasing since the first Healthcare Provision Decree (SUT) had been issued in 2007. The fact that the prices are not updated as they should be makes it quite difficult for both the medical device industry and the private hospitals.” Gökalp commented that considering that such systems as the product tracking system was set up in Turkey, the government may lead the way and coordinate various agencies to install such a system and to build infrastructure needed for it.
*Bu röportaj, Dünya Gazetesi‘nde 21 Şubat 2019 tarihli çıkan habere aittir.